Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
4
×
life sciences
fda
national blog main
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
europe top stories
national
new york blog main
san diego blog main
san diego top stories
san francisco blog main
akcea therapeutics
alnylam pharmaceuticals
arena pharmaceuticals
barry greene
billy dunn
biogen
biologic drugs
boston
boston university
boston xcon
boulder/denver blog main
boulder/denver top stories
boulder/denver xcon
cancer
cardiovascular disease
colorectal cancer
dan ollendorf
detroit blog main
detroit top stories
detroit xcon
digital health
drug development
drug prices
drug pricing
What
medicine
4
×
patients
4
×
drug
fda
friday
ago
alnylam
approve
approved
atrophy
awaits
biologic
biological
bottleneck
cancer
clinical
crossed
daily
decades
decision
development
discovered
dramatically
eisai
evrysdi
fingers
fixing
flags
genomic
green
higher
historic
home
incidence
intended
lights
liquid
lorcaserin
loss
making
Language
unset
Current search:
medicine
×
patients
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority